Merlin Biosciences

From Powerbase
Revision as of 15:36, 7 July 2016 by Matthew Pringle (talk | contribs) (People, contact info and resources added)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Overview

Merlin Biosciences was founded in 1996 by Christopher Evans. The aim of the company was to raise funds from investors to help support small, innovative bioscience companies.[1] Merlin Biosciences is now known as Excalibur Fund Managers.

Serious Fraud Office Investigation

In September 2005 Merlin Biosciences was placed under investigations by the Serious Fraud Office and the City of London Police following claims that around £2.5m was misappropriated from company funds to invest in Energist and Miracle Light. A four year investigation ensued but was subsequently dropped with the Serious Fraud Office stating it would "not be bringing any charges as a result of its investigation into the affairs of Merlin Biosciences. The Serious Fraud Office launched its enquiries in 2005 following a referral from the Financial Services Authority. Following a detailed review of the evidence gathered in the course of a thorough investigation, it has been concluded that there is insufficient evidence to provide a realistic prospect of conviction."[2]

Affiliations

People

Contact

Berkeley Square House
Berkeley Square
Mayfair
London, W1J 6BD
United Kingdom
Phone: 44 20 7887 7642
Fax: 44 20 7887 7650

Resources

Notes

  1. Heather Tomlinson, 'Fraud inquiry at pioneering biotech firm', 27 September 2005.
  2. Alistair Dawber, 'Sir Christopher Evans in the clear as SFO gives up fraud inquiry', The Independent, 13 November 2009.
  3. Data from Internet Archive holdings of the Science Media Centre website, 2002-2013.
  4. 'Company Overview of Excalibur Fund Managers Limited', Bloomberg, accessed 7 July 2016.